Role of P-selectin and anti-P-selectin monoclonal antibody in apoptosis during hepatic/renal ischemia-reperfusion injury

Table 1 The quantity of apoptotic bodies in hepatic and renal tissues of each group (mean ± SD, number/× 400)

	Renal ischemia-reperfusion group		Hepatic ischemia-reperfusion group
	n	Quantity of apoptotic bodies	n	Quantity of apoptotic bodies
Control group	5	9.0 ± 3.2	5	8.5 ± 3.4
Non-treatment group
1 h of reperfusion	5	23.4 ± 2.9ab	5	18.3 ± 3.5ab
3 h of reperfusion	5	131.6 ± 7.6ab	5	74.9 ± 6.8ab
6 h of reperfusion	5	209.6 ± 8.4ab	5	94.6 ± 8.1ab
24 h of reperfusion	5	427.8 ± 37.1ab	5	397.4 ± 40.2ab
mAb treatment group	20	13.0 ± 3.9a	20	13.1 ± 3.7a

Compared with control group:

^aP ＜ 0.01; compared with mAb treatment group:

^bP ＜ 0.01.